Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuki Tachibana
Observed name:
Yuki TACHIBANA
Institution:
Shionogi (Japan)
Observed institutions:
Hokkaido University,
Shionogi (Japan),
AIST Hokkaido,
National Institute of Advanced Industrial Science and Technology
ORCID:
0000-0001-6845-4453
Observed ORCID:
0000-0001-6845-4453
OpenAlex ID:
A5069827383
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
2022
·
Yuto Unoh
, Shota Uehara
, et al.
·
Journal of Medicinal Chemistry
·
663
Antifreeze Glycoproteins: Elucidation of the Structural Motifs That Are Essential for Antifreeze Activity
2004
·
Yuki Tachibana
, Garth L. Fletcher
, et al.
·
Angewandte Chemie International Edition
·
257
PDF
Effects of synthetic antifreeze glycoprotein analogue on islet cell survival and function during cryopreservation
2005
·
Shuichiro Matsumoto
, Michiaki Matsusita
, et al.
·
Cryobiology
·
82
Efficient and versatile synthesis of mucin-like glycoprotein mimics
2002
·
Yuki Tachibana
, Naoki Matsubara
, et al.
·
Tetrahedron
·
69
Antifreeze Glycoproteins: Elucidation of the Structural Motifs That Are Essential for Antifreeze Activity
2004
·
Yuki Tachibana
, Garth L. Fletcher
, et al.
·
Angewandte Chemie
·
54
Indazole-Based Potent and Cell-Active Mps1 Kinase Inhibitors: Rational Design from Pan-Kinase Inhibitor Anthrapyrazolone (SP600125)
2013
·
Ken-ichi Kusakabe
, Nobuyuki Ide
, et al.
·
Journal of Medicinal Chemistry
·
50
Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally
2023
·
Sho Kawashima
, Yuki Matsui
, et al.
·
Biochemical and Biophysical Research Communications
·
46
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2in vitroandin vivo
2023
·
Takayuki Kuroda
, Haruaki Nobori
, et al.
·
Journal of Antimicrobial Chemotherapy
·
45
PDF
Diaminopyridine-Based Potent and Selective Mps1 Kinase Inhibitors Binding to an Unusual Flipped-Peptide Conformation
2012
·
Ken-ichi Kusakabe
, Nobuyuki Ide
, et al.
·
ACS Medicinal Chemistry Letters
·
38
Peptide-to-Small Molecule: A Pharmacophore-Guided Small Molecule Lead Generation Strategy from High-Affinity Macrocyclic Peptides
2022
·
Shuhei Yoshida
, Shota Uehara
, et al.
·
Journal of Medicinal Chemistry
·
36
Sequential Glycoproteins: Practical Method for the Synthesis of Antifreeze Glycoprotein Models Containing Base Labile Groups
2004
·
Yuki Tachibana
, Kenji Monde
, et al.
·
Macromolecules
·
36
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model
2022
·
Haruaki Nobori
, Keita Fukao
, et al.
·
Journal of Antimicrobial Chemotherapy
·
33
PDF
Discovery of the Clinical Candidate S-892216 : A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19
2025
·
Yuto Unoh
, Keiichiro Hirai
, et al.
·
Journal of Medicinal Chemistry
·
29
PDF
Direct Observation of Sugar–Protein, Sugar–Sugar, and Sugar–Water Complexes by Cold‐Spray Ionization Time‐of‐Flight Mass Spectrometry
2004
·
Shin‐Ichiro Nishimura
, Noriko Nagahori
, et al.
·
Angewandte Chemie International Edition
·
21
Peptide-to-Small Molecule: Discovery of Non-Covalent, Active-Site Inhibitors of β-Herpesvirus Proteases
2023
·
Shuhei Yoshida
, Yusuke Sako
, et al.
·
ACS Medicinal Chemistry Letters
·
11
PDF
Pocket-to-Lead: Structure-Based De Novo Design of Novel Non-peptidic HIV-1 Protease Inhibitors Using the Ligand Binding Pocket as a Template
2022
·
Eiichi Kojima
, Atsuhiro Iimuro
, et al.
·
Journal of Medicinal Chemistry
·
11
Pharmacokinetic and Pharmacodynamic Analysis of the 3CL Protease Inhibitor Ensitrelvir in a SARS-CoV-2 Infection Mouse Model
2023
·
Keita Fukao
, Haruaki Nobori
, et al.
·
Viruses
·
10
PDF
Prophylactic effect of ensitrelvir in mice infected with SARS-CoV-2
2024
·
Haruaki Nobori
, Keiko Baba
, et al.
·
Antiviral Research
·
5
Structure-Based Drug Discovery of Non-SAM-Mimetic Bisubstrate Inhibitors against Nicotinamide N -Methyltransferase
2026
·
Shuhei Yoshida
, Noriyasu Kondo
, et al.
·
ACS Medicinal Chemistry Letters
·
4
PDF
Design, synthesis and biological evaluation of novel quinazolinedione derivatives as non-covalent SARS-CoV-2 3CL protease inhibitors
2025
·
Yoshiyuki Taoda
, Akihiro Hori
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
3
Titelbild: Antifreeze Glycoproteins: Elucidation of the Structural Motifs That Are Essential for Antifreeze Activity (Angew. Chem. 7/2004)
2004
·
Yuki Tachibana
, Garth L. Fletcher
, et al.
·
Angewandte Chemie
·
2
Direct Observation of Sugar–Protein, Sugar–Sugar, and Sugar–Water Complexes by Cold‐Spray Ionization Time‐of‐Flight Mass Spectrometry
2004
·
Shin‐Ichiro Nishimura
, Noriko Nagahori
, et al.
·
Angewandte Chemie
·
1
Optimization of pyridopyrimidinedione derivatives as non-covalent SARS-CoV-2 3CL protease inhibitors
2026
·
Yoshiyuki Taoda
, Keiichiro Hirai
, et al.
·
Bioorganic & Medicinal Chemistry Letters
Discovery of Ensitrelvir, an Oral Therapeutic Drug for COVID-19 Utilizing Crystal Structure
2024
·
Shiho YAMAMOTO
, Yuto UNOH
, et al.
·
Nihon Kessho Gakkaishi
Cover Picture: Antifreeze Glycoproteins: Elucidation of the Structural Motifs That Are Essential for Antifreeze Activity (Angew. Chem. Int. Ed. 7/2004)
2004
·
Yuki Tachibana
, Garth L. Fletcher
, et al.
·
Angewandte Chemie International Edition
Show more works
View as search
Works count:
26
Citation count:
1,506
H-index:
14
I10-index:
17
Year
Topic
Type